Astrazeneca's covid-19 vaccine doesn't raise the risk of a rare blood clotting disorder after a second dose, suggesting people shouldn't hesitate to get another one if they didn't have trouble after the first.
The estimated rate of the disorder, called thrombosis with thrombocytopenia syndrome (TTS), was 2.3 per million in people who received a second shot, according to data published in the medical journal The Lancet. That's comparable to what's found in an unvaccinated population. But the rate after a single dose was still higher, at 8.1 per million.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Scientist, Adcendo ApS 
Senior Drug Product Specialist - Zealand Pharma 
Associate Director/Senior Manager, Global Regulatory Affairs Project Lead - Genmab 
Director of Communications – Evaxion Biotech 
Analysis Chemist for Quality Control in Orifarm Manufacturing Viminco 
Bioinformatician / Immunoinformatician - Vaccibody 
Senior Clinical Research Specialist - Ambu 
A tech-savvy Project Manager Oncology (m/f/x) with a passion for communication and cross-functional collaboration - Daiichi-Sankyo 
Employee of the regulatory department with knowledge of food safety and legislation within dietary supplements and medicines 
Associate Director, PV QA - Y-mAbs Therapeutics 
Senior Downstream Scientist - Symphogen 
KLIFO is looking for a talented Medical Writer (DK, SE or DE) 
Global Senior Medical Advisor – Neurology Pipeline Projects, Lundbeck